The Board of Pharmacy published a guidance document for pharmacy technicians administering immunizations.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Prior to the legislature adjourning on April 28, SB 131, legislation that was amended to include extending the authority for pharmacy technicians to administer vaccines was sent to Gov. Laura Kelly (R). She signed it into law on May 1. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, the pharmacy technician vaccine administration bill, continues to advance. It was heard in the Senate Public Health and Welfare Committee on March 15^th.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, the pharmacy technician vaccine administration bill, was amended in Committee and passed the full House by a vote of 119-3. This bill was referred to the Senate Public Health and Welfare Committee and will be heard on March 15.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, legislation that would add pharmacy technicians over 18 years of age to the list of those that can administer vaccinations under Kansas law was amended and reported favorable from the House Health and Human Services Committee on February 6. Next, the bill goes to the full House. NACDS pharmacist and technician constituents are urged to contact their state representative and ask them to vote for HB 2263.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Prior to adjournment last month, Gov. Laura Kelly (D) signed into law SB (Senate Bill) 200, a bill expanding the pharmacist’s scope of practice to include initiation of therapy for flu, strep or urinary tract infection pursuant to a Statewide Protocol adopted by the existing Collaborative Drug Therapy Management Advisory Committee. Also signed into law was SB 28 that sets up a regulatory framework, adjusts the MAC (Maximum Allowable Cost) appeal law, and requires Pharmacy Benefit Managers to be licensed by the Insurance Department. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Two Senate bills advancing of interest to pharmacies were amended and are now pending action by the full House. SB 200 allows pharmacists to test and initiate therapy for strep, flu, and urinary tract infections under protocols developed and approved by the Collaborative Drug Therapy Management Advisory Committee. SB 28 requires PBMs (Pharmacy Benefits Managers) to be licensed and regulated by the Insurance Department. It also addresses MAC (Maximum Allowable Cost) pricing and delineates what items a PBM (Pharmacy Benefit Manager) can request during a MAC appeal. If these bills pass the House, they will be returned to the Senate for ultimate action to concur with the House changes. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 200, legislation expanding the pharmacist's scope of practice to include initiation of therapy for influenza, strep throat and urinary tract infection pursuant to a statewide protocol adopted by the collaborative drug therapy management advisory committee, passed the Senate by a vote of 37-2. It was referred to the House Health and Human Service Committee for further action. 

Also in Kansas, legislation that would establish a joint committee on pharmacy workplace conditions and patient safety to conduct a study and issue a report to the legislature was referred to the House Health and Human Services Committee. HB 2698 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Below are highlights from the September issue of the Board of Pharmacy newsletter.  See the newsletter for details and more information.

• The Board continues to provide updates on its COVID webpage, including information about operations, waivers, renewals, exams, inspections, frequently asked questions and more. The most recent memo was updated on August 25.
• Pharmacies only need to upload the first page when submitting proof of a National Association of Boards of Pharmacy® (NABP®) Verified Pharmacy Program® inspection to the Board.
• Laura Kelly (D) reappointed Jonathan Brunswig, PharmD, RPh, and Bill Walden, RPh, to the Board and appointed new public member, Lucinda Noches Talbert. All will serve a four-year term, ending in 2025.
• K-TRACS, the Kansas prescription drug monitoring program, will explore interest in peer-to-peer education about K-TRACS utilization via outreach to pharmacies.
• Updates on pharmacist technician certification examinations, CE and renewals are now available.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.